# Profound Medical Corp.: filings

PROF · Nasdaq · CIK 1628808 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prof.md) · [Financials](/companies/prof/financials.md) · [Filings](/companies/prof/filings.md) · [Insiders](/companies/prof/insiders.md)

## Reports and events: 203 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 144, 8-K 47, SC 13G/A 20, SUPPL 10, SC 13G 7, 144 6, 10-Q 5, 40-F 5, EFFECT 5, F-X 4, 6-K/A 3, F-10 3, F-10/A 3, S-8 3, 10-K 2, CORRESP 2, F-X/A 2, S-3 2, SCHEDULE 13G/A 2, 20FR12B 1, 4 1, 424B5 1, 8-A12B 1, CERT 1, D 1, D/A 1, FWP 1, RW 1, UPLOAD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:45 ET | [8-K](/filings/0001171843-26-006781.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006781 |
| 2026-10-14 | 12:00 ET | [8-K](/filings/0001171843-26-006615.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006615 |
| 2026-10-09 | 17:11 ET | [8-K](/filings/0001171843-26-006559.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006559 |
| 2026-10-07 | 20:45 ET | [8-K](/filings/0001171843-26-006499.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006499 |
| 2026-09-04 | 01:00 ET | [8-K](/filings/0001171843-26-005884.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005884 |
| 2026-09-03 | 11:07 ET | [8-K](/filings/0001171843-26-005868.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005868 |
| 2026-08-17 | 12:35 ET | [8-K](/filings/0001171843-26-005580.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005580 |
| 2026-08-17 | 11:30 ET | [8-K](/filings/0001171843-26-005575.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005575 |
| 2026-08-13 | 20:30 ET | [8-K](/filings/0001171843-26-005500.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005500 |
| 2026-08-06 | 20:32 ET | [10-Q](/filings/0001104659-26-092066.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092066 |
| 2026-08-06 | 20:20 ET | [8-K](/filings/0001171843-26-005322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005322 |
| 2026-07-24 | 15:58 ET | [8-K](/filings/0001171843-26-004863.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004863 |
| 2026-07-16 | 20:45 ET | [8-K](/filings/0001171843-26-004740.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004740 |
| 2026-07-15 | 12:00 ET | [8-K](/filings/0001171843-26-004654.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004654 |
| 2026-05-15 | 20:06 ET | [8-K](/filings/0001104659-26-062509.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-062509 |
| 2026-05-14 | 21:06 ET | [8-K](/filings/0001171843-26-003441.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003441 |
| 2026-05-07 | 20:31 ET | [10-Q](/filings/0001104659-26-057198.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057198 |
| 2026-05-07 | 20:12 ET | [8-K](/filings/0001171843-26-003160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003160 |
| 2026-04-16 | 12:53 ET | [8-K](/filings/0001171843-26-002497.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002497 |
| 2026-04-14 | 11:33 ET | [8-K](/filings/0001171843-26-002426.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002426 |
| 2026-04-01 | 12:29 ET | [8-K](/filings/0001171843-26-002146.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002146 |
| 2026-03-27 | 12:18 ET | [8-K](/filings/0001171843-26-001971.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001971 |
| 2026-03-13 | 14:35 ET | [8-K](/filings/0001171843-26-001553.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001553 |
| 2026-03-10 | 20:05 ET | [8-K](/filings/0001104659-26-025822.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-025822 |
| 2026-03-09 | 13:55 ET | [8-K](/filings/0001171843-26-001406.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001406 |
| 2026-03-05 | 21:32 ET | [10-K](/filings/0001104659-26-024153.md) | Annual report, period 2025-12-31 | 0001104659-26-024153 |
| 2026-03-05 | 21:10 ET | [8-K](/filings/0001171843-26-001362.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001362 |
| 2026-02-12 | 21:35 ET | [8-K](/filings/0001171843-26-000791.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000791 |
| 2026-02-12 | 13:33 ET | [8-K](/filings/0001171843-26-000772.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000772 |
| 2026-02-05 | 13:05 ET | [8-K](/filings/0001171843-26-000643.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000643 |
| 2026-01-28 | 23:17 ET | [8-K](/filings/0001171843-26-000450.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000450 |
| 2026-01-15 | 12:35 ET | [8-K](/filings/0001171843-26-000273.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000273 |
| 2026-01-12 | 16:37 ET | [8-K](/filings/0001171843-26-000210.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000210 |
| 2026-01-06 | 18:39 ET | [8-K](/filings/0001171843-26-000096.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000096 |
| 2025-12-31 | 01:47 ET | [8-K](/filings/0001104659-25-125344.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-125344 |
| 2025-12-19 | 21:36 ET | [8-K](/filings/0001104659-25-123211.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-123211 |
| 2025-11-28 | 18:55 ET | [8-K](/filings/0001171843-25-007654.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007654 |
| 2025-11-13 | 21:30 ET | [10-Q](/filings/0001104659-25-111378.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111378 |
| 2025-11-12 | 14:00 ET | [8-K](/filings/0001171843-25-007224.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007224 |
| 2025-11-12 | 13:01 ET | [8-K](/filings/0001171843-25-007221.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007221 |
| 2025-11-12 | 01:43 ET | [8-K](/filings/0001171843-25-007188.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007188 |
| 2025-10-07 | 12:06 ET | [8-K](/filings/0001171843-25-006317.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006317 |
| 2025-08-14 | 20:11 ET | [8-K](/filings/0001171843-25-005427.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005427 |
| 2025-08-14 | 20:01 ET | [10-Q](/filings/0001410578-25-001809.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001809 |
| 2025-06-04 | 17:30 ET | [8-K](/filings/0001171843-25-003672.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-003672 |
| 2025-05-14 | 21:20 ET | [8-K](/filings/0001171843-25-003194.md) | 5.07 Shareholder vote results | 0001171843-25-003194 |
| 2025-05-08 | 20:51 ET | [8-K](/filings/0001171843-25-002987.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002987 |
| 2025-05-08 | 20:32 ET | [10-Q](/filings/0001410578-25-001112.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001112 |
| 2025-04-29 | 11:45 ET | [8-K](/filings/0001171843-25-002572.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002572 |
| 2025-04-29 | 00:01 ET | [8-K](/filings/0001171843-25-002561.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002561 |

Page 1 of 5. [Older](/companies/prof/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.